Exhibiting at VIV Asia 2025

Shanghai Sunrise Chemical Co., Ltd. is a professional pharmaceutical manufacturer and research-driven enterprise based in Shanghai, China. Specializing in the development, production, and international distribution of both generic and innovative drugs, Sunrise Chemical plays a significant role in supplying high-quality pharmaceutical formulations to global healthcare markets. With a strong emphasis on R&D, regulatory compliance, and production excellence, the company has established itself as a trusted partner for pharmaceutical companies, distributors, and healthcare institutions worldwide.

Company Background

Established in one of China's most economically advanced regions, Shanghai Sunrise Chemical Co., Ltd. has grown with the country's pharmaceutical innovation initiatives. The company’s vision is centered on making safe, effective, and affordable medications accessible across global markets. Sunrise operates with a dual focus on generics for therapeutic reliability and innovative drugs to meet unmet medical needs, ensuring balanced development across mature and emerging sectors.

The company benefits from access to Shanghai’s extensive biopharma talent pool, advanced logistics infrastructure, and proximity to regulatory bodies and academic partnerships.

Core Business and Product Portfolio

Sunrise Chemical’s business is structured around two primary pharmaceutical segments:

• Generic Drugs

  • Development and manufacturing of a broad range of oral solid dosage forms, injectables, and topical agents
  • Therapeutic categories include anti-infectives, cardiovascular, gastrointestinal, and metabolic disorders
  • Products formulated to meet USP/EP/BP pharmacopoeia standards, suitable for domestic and export markets
  • Committed to bioequivalence (BE) studies for international regulatory submission

• New Drugs

  • R&D-driven pipeline focused on novel chemical entities (NCEs) and value-added reformulations
  • Collaboration with academic institutions for clinical research, compound screening, and preclinical evaluations
  • Target areas include oncology, CNS (central nervous system), and autoimmune conditions

These two categories are supported by integrated capabilities in API sourcing, formulation development, and packaging solutions, ensuring end-to-end pharmaceutical manufacturing.

Unique Selling Proposition (USP)

Shanghai Sunrise Chemical’s market strengths include:

• R&D-centric business model, integrating drug discovery, formulation development, and regulatory science
• Capabilities to produce both high-volume generics and specialty pharmaceuticals
• Regulatory adaptability, with dossiers prepared in CTD format for seamless filing in regulated and semi-regulated markets
• Commitment to quality-by-design (QbD) and continuous process improvement
• Experienced leadership team with international pharma background, ensuring global market alignment

This multifaceted positioning allows Sunrise to be competitive across hospital procurement, pharmacy retail, and B2B supply chains.

Financial & Export Performance

Though privately held, Sunrise Chemical maintains active participation in global pharmaceutical trade:

• Export Markets: Southeast Asia, Middle East, Africa, Eastern Europe, and Latin America
• Supplies to government tender programs, NGO health initiatives, and private hospitals
• Frequent exhibitor at CPhI Worldwide, API China, and PharmChina
• Supported by GMP-certified production facilities, enabling finished dosage exports under strict compliance

The company’s expanding footprint reflects strong demand for quality-assured Chinese generics, particularly in emerging markets.

Target Market

Shanghai Sunrise Chemical serves a broad international customer base, including:

• Pharmaceutical distributors
• Hospital and institutional procurement agencies
• OTC and prescription (Rx) product marketers
• Contract development and manufacturing organizations (CDMOs)
• Regulatory agents and licensing partners

Its formulation and development services are ideal for partners seeking registration-ready products or branded generic collaborations.

Capabilities

Sunrise Chemical operates advanced manufacturing and R&D infrastructure, offering:

• GMP-compliant production lines for tablets, capsules, injections, and creams
• Dedicated analytical labs for stability testing, dissolution profiling, and impurity analysis
• Pilot-scale facilities for process development and tech transfer
• End-to-end dossier development and regulatory filing support
• Custom manufacturing services with strict intellectual property confidentiality

This infrastructure allows flexible production volumes and tailored solutions based on client needs.

Certifications and Compliance

Shanghai Sunrise Chemical aligns with global pharmaceutical standards, ensuring:

• GMP Certification from the Chinese National Medical Products Administration (NMPA)
• Production and testing according to ICH, WHO, and PIC/S guidelines
• CTD-format dossiers, bioequivalence data, and validation packages for international registration
• Strict compliance with ISO9001 quality systems and environmental management protocols

This robust compliance framework allows Sunrise to operate in both regulated and semi-regulated markets confidently.

Customer Testimonials

Though formal testimonials are not listed, long-term buyer relationships and trade platform feedback highlight:

• High consistency in product quality and regulatory documentation
• Professionalism in international communication and regulatory support
• On-time shipments and support for multilingual product registration
• Technical responsiveness and post-shipment collaboration on product training and positioning

These strengths make Sunrise a preferred supplier for reliable generic formulations and technical licensing.

Achievements and Recognition

• Approved manufacturer for multiple regional health ministries
• Successful registration of finished dosage forms in over 15 countries
• Expanded portfolio to include value-added formulations, such as controlled-release and combination therapies
• Recognized for innovation in formulation science and clinical collaboration
• Partnered with universities and clinical research centers for joint drug development

Shanghai Sunrise Chemical Co., Ltd. continues to rise as a competitive force in the global pharmaceutical industry. By combining scientific rigor with market insight and regulatory strength, the company delivers value to healthcare providers, governments, and patients across continents.